322 related articles for article (PubMed ID: 17056371)
21. Transscleral permeation of subtenon triamcinolone in different vitreoretinal diseases.
Shen L; Mao J; Chen Y; Sun S; Han Y; Cheng L
Ophthalmology; 2015 Mar; 122(3):649-51. PubMed ID: 25439434
[No Abstract] [Full Text] [Related]
22. Intravitreal triamcinolone acetonide in eyes with recurrent postvitrectomy diabetic vitreous hemorrhage.
Lee SY; Yoon YH; Lee HG; Chung H; Kim JG
Am J Ophthalmol; 2006 Sep; 142(3):501-3. PubMed ID: 16935603
[TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy.
Paccola L; Jorge R; Barbosa JC; Costa RA; Scott IU
Acta Ophthalmol Scand; 2007 Sep; 85(6):603-8. PubMed ID: 17459031
[TBL] [Abstract][Full Text] [Related]
24. Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity.
Lakhanpal RR; Fortun JA; Chan-Kai B; Holz ER
Retina; 2006 Sep; 26(7):736-40. PubMed ID: 16963844
[TBL] [Abstract][Full Text] [Related]
25. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
Lee EW; Hariprasad SM; Mieler WF; Newman TL; Apte RS
Am J Ophthalmol; 2007 Feb; 143(2):365-7. PubMed ID: 17258540
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
28. Systemic absorption of triamcinolone acetonide after posterior sub-Tenon injection.
Zaka-ur-Rab S; Mahmood S; Shukla M; Zakir SM; Khan BA; Owais M
Am J Ophthalmol; 2009 Sep; 148(3):414-9. PubMed ID: 19464668
[TBL] [Abstract][Full Text] [Related]
29. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.
Benz MS; Albini TA; Holz ER; Lakhanpal RR; Westfall AC; Iyer MN; Carvounis PE
Ophthalmology; 2006 Jul; 113(7):1174-8. PubMed ID: 16647122
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
32. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
[TBL] [Abstract][Full Text] [Related]
33. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
34. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
Yi NY; Davis JL; Salmon JH; Gilger BC
Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
[TBL] [Abstract][Full Text] [Related]
35. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
36. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
[TBL] [Abstract][Full Text] [Related]
37. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
38. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Kang SW; Park SC; Cho HY; Kang JH
Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
[TBL] [Abstract][Full Text] [Related]
39. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
40. Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
Taban M; Singh RP; Chung JY; Lowder CY; Perez VL; Kaiser PK
Am J Ophthalmol; 2007 Jul; 144(1):50-54. PubMed ID: 17601427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
